00897.TW Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF

- TWD
No recent price
Total assets
1.87B
Expense ratio
-
Dividend yield
-
1-year return
+75.91%
Holdings
10
Since
2021

Fund data as reported by the issuer, updated Nov 8, 2026. Total assets are in the fund's base currency.

What does 00897.TW invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (66.3%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (70.1%)
  • Top 3 holdings: 22.9% of the fund

Asset allocation

  • US stocks 66.3%
  • Non-US stocks 29.5%
  • Cash 3.4%

Top holdings

  • Moderna Inc 10.64%
  • Twist Bioscience Corp 7.42%
  • Iovance Biotherapeutics Inc 4.81%
  • Genmab A/S 4.01%
  • Revolution Medicines Inc 3.88%
All holdings, sectors and regions

Fubon NYSE FactSet Global Genomics and Immuno Biopharma ETF performance

Sharpe ratio 1.19
This year
+66.06%
1 year
+75.91%
3 years
+30.74%
5 years
-0.76%

Volatility 25.5% over 1 year and 22.6% over 3 years. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

00897.TW price

Prices on the chart can differ slightly from the closing prices StockSummer shows.